{"name":"William Demant (Demant A/S)","slug":"demant","ticker":"DEMANT","exchange":"Copenhagen","domain":"demant.com","description":"Demant A/S is a Danish international company involved with hearing care, hearing aids and audiometric equipment. It is headquartered in Smørum and had a revenue of kr. 22,400,000,000 in 2024.","hq":"Smørum, Denmark","founded":1904,"employees":"~75,000","ceo":"Søren Nielsen","sector":"Hearing Care / MedTech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"153400000000","metrics":{"revenue":3000000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Oticon Opn patent cliff ($100M at risk)","drug":"Oticon Opn","type":"patent_expiry","sentiment":"negative"},{"date":"2030-06-01","label":"Phonak Marvel patent cliff ($80M at risk)","drug":"Phonak Marvel","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"William Demant reports strong Q4 2023 results","summary":"The company reported a 12% increase in revenue and a 15% increase in operating profit compared to the same period last year.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"William Demant acquires hearing aid manufacturer","summary":"The company acquired a leading hearing aid manufacturer, expanding its product portfolio and market presence.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5NZ0ZESVZNQ1FVRE1qbWdLaE5iTnAzRkRRM1VVTmVKV0NYRkZ4R05EOWdILVg4UW5BZEpvMEhKcWZIcDEtZVdyWkdBQjBHRE5ObnVldTlIVFp3SmhGZndTQXVtQTl2TjZFM2NfVg?oc=5","date":"2026-03-06","type":"regulatory","source":"medwatch.com","summary":"Demant shareholders elect Kristian Villumsen as chairman - medwatch.com","headline":"Demant shareholders elect Kristian Villumsen as chairman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPanJHR3c1djNFbXJsY1VLUmk5S2FYR1VCMjdCSEMxamQtLTZaTWFqRkxJeVFwTFhSZmR0X29jNWtrU2RVcm9WcWFKVHBSQ0pFOHBLUUk2ZkJRXzFyOW0tVXJBck9kWTdzS0toNE5ZZndEOWN4aThPVWtXYzd3UV8yVmt5SHpFMnVXRXVqZHgwUFN2ZTBZam5LVGk2dXBPU09VcVlwM2NXMThDNjVORGJHQXFLYXNpSlZPa3ZVVW84eGdNakpsdTVZWkl5LUJZRE4wRGdFSjhLbGlOMHRyeWx4cGVVbFUzMXJYTk1LOA?oc=5","date":"2025-11-06","type":"earnings","source":"Business Wire","summary":"Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire","headline":"Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNV2ZibGNUSFlNOFlHZU5jbkJBbThaUzFubGJrZi1WNU13ZXlVNkQ3QmdqVnkzbVlOVjdEOVRNVTlLRXpwUUswaTl0MGotQlBwd1RwT2hISWhZT05NS3ptU1V4N0U2cXJOODQ2MnFHVTFVMVZZUDVSWWVaOG1vOVc4c3pWbDRUNkdzZXZfcTZEQzYyV2F6MEhlXzFHbS1SaGdQUlJmYW5YUWp0c1JjT1kzbjZ0Q2ZDMW9vNE9DbjI3ZWNYRWxKQmxjeUdZdHpYTzNs?oc=5","date":"2025-10-29","type":"earnings","source":"Reuters","summary":"SHORT TAKE Amplifon posts Q3 profit fall, confirms 2025 guidance - Reuters","headline":"SHORT TAKE Amplifon posts Q3 profit fall, confirms 2025 guidance","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1ydGNFSnhiRlNSSEZLc3EzNmdSeVVrc0J1dDdvcmw5SUtaRHlIQWxnYk1iU1BKdlJkU1NqQVV6VGRpelNhRG16RnR1RUsyS2Y2MnRVXzAzUm52SkxrMkNMSVNnVnp5azQxbUFaZQ?oc=5","date":"2025-10-24","type":"regulatory","source":"medwatch.com","summary":"Private equity firm sees growth opportunities in Demant's scrapped business area - medwatch.com","headline":"Private equity firm sees growth opportunities in Demant's scrapped business area","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE43dGQ5TUdOdldLaTkyWUp3aWhjaUtGbElTa2JPd1ZyMHBfWmYzd1djNGU2X0o4TWdPU3FDT2lBVmhiYTlGRzBpbk1xVHI1ODd1dkthaG0zemI4dFQyeUdEUDJ3aDBnelpoWnlfRQ?oc=5","date":"2025-10-10","type":"regulatory","source":"medwatch.com","summary":"Demant chairman won't seek re-election, poised to replace Lars Rasmussen at Coloplast - medwatch.com","headline":"Demant chairman won't seek re-election, poised to replace Lars Rasmussen at Coloplast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNLXJTdkFmMmlHSTgzM0J3NEpGUVpBUGlkeTNtQzV0T3NCdmZyUlpINmhZTWFrUTQyQ05KbmtLX0RNdUVMdHBiRldISHFXUzIyMVBCaDhRaVllLVBsbzBLb2w3NUFtSDlDWDZpcm1saER5ZjI2dlZvNHRuS053X3pJUmNrVmNqNTMxYUVIZGZkRmkzMUhLdldIZg?oc=5","date":"2025-09-08","type":"regulatory","source":"San Diego Business Journal","summary":"Lineage Nabs $12M Demant Partnership - San Diego Business Journal","headline":"Lineage Nabs $12M Demant Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOT1V4OVlnRHRhUFllMW8wUlVfZ1ZHVDRkbmVHMC16eGVJVy1USGdhYmd5UU5heG5rVW1nNFNjNmx1Ulh3MEpXSG5YTzAzZVlmRkdGZWJSazZqajl4ZmRVcHlNcDl3UE9jQVNJWFRMY0VQSi1jbjRwTkgyUnhMcm1MMzhXU0ZaUmpwRzNfckJwRC02aVlmV3NWclJwWmFPX2NlUzRqMjJxVHZCZ1NTMjNBRHhkTXVUWTYyUXFhaDBnMnVGaDlOTzM4SjRCWWk0b3puNEJZeXBNLXVXMVlyYVBJMkFTdXY?oc=5","date":"2025-08-27","type":"regulatory","source":"BioSpace","summary":"Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss - BioSpace","headline":"Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQSUEyd3FjN1Jma1ZNMlFRS1lEWVM0dzllcm1oclFCRzlOT1g5YnJYZE8xbVZDbHprZ1dpOEtKZmdYd1lOeENsVXFZLXp5ZTdZRjN0bjN5T19oZF9RbVRhN1F6N0VabTZVZ3BjaDZ4N3pDMExjSy1tMjhYWk1xdUx6OEoyRDBCNWwwaFE1RU5QLUxvVG0ya1NPYmFxcw?oc=5","date":"2025-06-11","type":"regulatory","source":"Reuters","summary":"Demant expands in German through 700 million euro Kind deal - Reuters","headline":"Demant expands in German through 700 million euro Kind deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMDg5X1p5dUxYUnNBZVQzbF9rUlg0VTN0S1FMQkFQN1RNb1M3TzlPaUNhc0k4Q0R0RC11QTRYZjg5Y1dOaE4wUFRldlZkcmt2N0lkbXlkTTdmb1J4NzI4eEV3ajBBS1FMcXRReWRyU3o0TG92dHh0cmFPQUVCRnpXZzg4YnFidDlQWERDRmFLYlc2c2tDRFJaMmpYSy03U2o3XzB2Y2tFY0I5YXVIWEU0OW0tWm5PdzBm?oc=5","date":"2025-05-14","type":"pipeline","source":"bloomberg.com","summary":"Trump’s Trade War Spares an Industry Europe Dominates: Hearing Aids - bloomberg.com","headline":"Trump’s Trade War Spares an Industry Europe Dominates: Hearing Aids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hNlIzVEJCaHA0OXJEQ083Z0ViM0FGa2FVS2VjbjRnaTBRaE12R0hLWXV2TFNzWDRTNzRZeHJOeDRpWVE0czl3dnNpbXh2U044YmdReTdyVGc?oc=5","date":"2025-04-23","type":"regulatory","source":"medwatch.com","summary":"Leo Pharma chairman exits William Demant Foundation - medwatch.com","headline":"Leo Pharma chairman exits William Demant Foundation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1obnFjZ1lIcDFhaTZyRTZaWUZXUEVoRDVXSkxRNEMwQW5RbWF6NFBEdEJjMTN3Ump2VW9oZlR5cmNjZWd1RnpIU1RpSlRuM2JicC1YWHNiVzZld0Zmb2hHcXZNS2VURTZudFBnQW5Nd1FYeURQ?oc=5","date":"2024-11-22","type":"pipeline","source":"Market.us","summary":"Assistive Technology Market To Reach US$ 36.6 Billion By 2033 - Market.us","headline":"Assistive Technology Market To Reach US$ 36.6 Billion By 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOeDRYemVLVzBsaW9BRnd0UGlETU5ydzJXV0lkQlc0by1iaER0blNTMkUwN1IyV1hYOERxa0Q2enFJTXlzaGZISkRpUmVFMDhGMHZZMDVja3Vpc3VtaGdaWlllRnoxS3VfbUhCYllPaTltZnVUT2pYUHpYSzQ3TVk2M0k5RGpsYlJmRTI0QXdXRmo5Y1FsVFVucFRTZ1NNa2ZCQ2Q4T0xrdVh4eTRNeTRudjRxWDRPWm1mSUt1dUVyb29fVlFSd1dLTTZRX0d0cTV2MGtrS3RFUmN6ZHR5LWZBSg?oc=5","date":"2023-11-21","type":"pipeline","source":"PharmiWeb.com","summary":"Global Custom Hearing Aids Industry is set to reach a valuation of US$ 18,861.5 Million by 2033, as - PharmiWeb.com","headline":"Global Custom Hearing Aids Industry is set to reach a valuation of US$ 18,861.5 Million by 2033, as","sentiment":"neutral"}],"patents":[{"drugName":"Oticon Opn","drugSlug":"oticon-opn","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Phonak Marvel","drugSlug":"phonak-marvel","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":80000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sonova","Sivantos"],"therapeuticFocus":["Hearing Loss","Hearing Impairment"],"financials":null,"yahoo":null}